SCHEMBL14657887

SCHEMBL14657887

c1ccc(-n2c3ccccc3c3cccc(-c4cccc5c4[nH]c4ccccc45)c32)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 1/20 0.46
▸ ATM Q13315 1/20 0.46
▸ L3MBTL1 Q9Y468 1/20 0.46
▸ PARP14 Q460N5 12/20 0.43
▸ BCHE P06276 1/20 0.41
▸ KIF11 P52732 1/20 0.41
▸ NQO2 P16083 1/20 0.40
▸ PDE7A Q13946 1/20 0.40
▸ PDE7B Q9NP56 1/20 0.40
▸ GABRP O00591 1/20 0.40
▸ GABRD O14764 1/20 0.40
▸ GABRA1 P14867 1/20 0.40
▸ GABRB1 P18505 1/20 0.40
▸ GABRG2 P18507 1/20 0.40
▸ GABRB3 P28472 1/20 0.40
▸ GABRA5 P31644 1/20 0.40
▸ GABRA3 P34903 1/20 0.40
▸ GABRA2 P47869 1/20 0.40
▸ GABRB2 P47870 1/20 0.40
▸ GABRA4 P48169 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15073661 0.85 KDM4E (0.52) KDM4EATML3MBTL1KIF11NQO2
SCHEMBL29506368 0.85 KDM4E (0.52) KDM4EATML3MBTL1KIF11NQO2
SCHEMBL31673 0.85 KDM4E (0.52) KDM4EATML3MBTL1KIF11NQO2
SCHEMBL29470200 0.85 KDM4E (0.52) KDM4EATML3MBTL1KIF11NQO2
SCHEMBL23568617 0.83 KDM4E (0.46) KDM4EATML3MBTL1PDE7APDE7B
SCHEMBL29533436 0.83 PARP14 (0.46) KDM4EATML3MBTL1PARP14KIF11
SCHEMBL20706844 0.83 L3MBTL1 (0.65) KDM4EATML3MBTL1DUSP3
SCHEMBL26646699 0.83 PARP14 (0.46) KDM4EATML3MBTL1PARP14KIF11
SCHEMBL30017427 0.83 L3MBTL1 (0.65) KDM4EATML3MBTL1DUSP3
SCHEMBL1193726 0.83 GABRP (0.40) KDM4EATML3MBTL1PARP14BCHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020032424-A1 ORGANIC ELECTRONIC ELEMENT COMPRISING, AS HOST MATERIAL, MIXTURE OF DIFFERENT KINDS OF COMPOUNDS, AND ELECTRONIC DEVICE THEREOF 덕산네오룩스 주식회사 2020-02-13 — — WO disclosed
WO-2020032447-A1 ORGANIC ELECTRONIC ELEMENT COMPRISING, AS HOST MATERIAL, MIXTURE OF DIFFERENT KINDS OF COMPOUNDS, AND ELECTRONIC DEVICE THEREOF 덕산네오룩스 주식회사 2020-02-13 — — WO disclosed
US-9422287-B2 Bridged triarylamines and -phosphines as materials for electronic devices MERCK PATENT GMBH (DE) 2016-08-23 — — US disclosed
US-20130026422-A1 BRIDGED TRIARYLAMINES AND -PHOSPHINES AS MATERIALS FOR ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2013-01-31 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130026422-A1 BRIDGED TRIARYLAMINES AND -PHOSPHINES AS MATERIALS FOR ELECTRONIC DEVICES TEC, PNMT, TES KDM4E 2344/4885ATM 1707/4885L3MBTL1 3269/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback